buy danisco
decemb
bloomberg recent report seriou contend dupont nutrit bioscienc
unit compani midst challeng frutatom integr manag
credibl question believ time wors contempl
deal deal ill-advis imposs rule introduc dupont key
attract assess implic report
dupont appear make good strateg sens
merg dupont could make good strateg sens creat new
ingredi pf sale complementari technolog across specialti
cultur enzym flavor well bulk ingredi emulsifi iff-dupont would
one-stop-shop ingredi sector
although deal look ill-advis risk anoth bout indigest
one year challeng frutarom integr would brave enough
contempl addit deal fear histori repeat view
integr risk materi materi de-rat pf group look highli like recent low
ebitda would impli fair valu downsid
deal no-deal rate under-perform
under-perform rate stand-alone basi given sluggish momentum
legaci view frutarom unlik return mid-singl digit growth talk
anoth materi transact shortli valu destruct frutarom deal serv rais
question mark compani focu sharehold valu creation view
exan bnpp estim thomson reuter consensu list currenc dividend reinvest
date time london time invest recommend finalis may differ date time broad
dissemin websit see appendix analyst certif import disclosur non-u research analyst disclosur
dupont nutrit bioscienc
might look dupont
invest case valuat risk
compani profil financi highlight
bloomberg report sunday seriou contend merg dupont
nutrit bioscienc unit excerpt articl shown
vie kerri deal dupont nutrit busi bloomberg
intern flavor fragranc inc emerg strong contend
purchas dupont inc nutrit divis challeng ireland kerri group
billion asset accord peopl knowledg matter
kerri negoti dupont winner could reach
deal year-end peopl said ask identifi discuss
privat transact creat new compani compris bidder asset
dupont nutrit busi spun exist investor peopl
dupont sharehold emerg so-cal revers morri trust
signific stake busi peopl said new compani aim
investment-grad credit rate board includ director dupont
bidder peopl said transact like take least year close
repres dupont kerri declin comment discuss
compani could still fall apart dupont could opt spin-off instead peopl
present dupont chairman ed breen chief execut offic marc doyl
distinct altern kerri rmt easier two compani
iff billion purchas frutarom industri ltd last year still absorb
manag time increas leverag kerri irish compani
deep root dairi industri that keen expand food ingredi kerri
trade higher earn multipl offer potenti bigger valuat
uplift dupont sharehold
dupont opt tax-effici option reward sharehold valu
nutrit busi wallow industri level part diversifi
deal would biggest ever make flavor fragranc
food beverag person care household product compani last big
acquisit food-flavor industri last year bought israel frutarom
industri ltd billion includ debt
kerri long want expand healthi bacteria strain ingredi found
dietari supplement chees bakeri product nutrit product claim
sort role assist diseas treatment prevent kerri heritag
lie milk chees dairi product compani collect billion liter
milk year small famili farm southwest ireland
outlin kerri buy danisco believ merger
kerri make strateg sens reduc integr valuat risk
emerg eleventh hour come big surpris remain
seen whether dupont view realist partner could add valu
inclin disagre thrown last minut help final
negoti kerri
-dupont deal seem ill-advis one never say never
bid paid ebitda frutarom note introduc
strateg rational consider attempt look financi implic
background iff/frutarom pleas refer pain gain
question frutarom indigest downgrad under-perform
dupont nutrit bioscienc
dupont nutrit bioscienc diversifi ingredi busi headquart
copenhagen denmark becam part dupont follow public take-over
danisco list denmark sinc busi grown
diversifi number acquisit includ pharma food
microbi control health nutrit
busi broad exposur rang probiot cultur
enzym textur sweeten protein solut end-market also
broad rang food beverag dietari supplement pharma home
person care bioethanol anim feed see bare overlap
focus flavor fragranc number adjac acquir
frutarom
figur dupont organis around platform
show overview bs sale exposur sub-platform
sale sub-platform
sale geographi
busi report non-cor
figur dupont divers exposur across food beverag pharma
busi undergon chang past year perhap prepar
exit
sinc june former nutrit food ingredi industri
bioscienc industri enzym oper segment repackag platform
describ
number non-strateg area biomateri clean technolog
shift dupont non-cor segment
margin dilut natur color busi exit ddw juli
former presid industri bioscienc william feeheri left compani
entir busi leadership matthia heinzel former
presid nutrit
overview dupont bs key financi courtesi chemic team
compani exan bnp pariba estim note ebita disclos estim
chemic team sub-segment estim shown food beverag
largest busi area lowest margin
figur dupont estim platform
health
bioscienc
dupont diversifi busi number attract exposur look
complementari
might look dupont
would take seriou look dupont middl
dupont complementari
evolv busi model focus flavor fragranc
player becom diversifi player mani adjac exposur
pursuit diversif one key reason paid high price
ebitda frutarom merg dupont would add addit technolog
figur frutarom dupont complementari
frutarom technolog exposur summaris dupont
other note dupont exposur flavor exit
firmenich recent sold natur color busi ddw
discuss earlier section
figur dupont divers portfolio complementari
divers exposur advantag custom increasingli ask
favour supplier broader multi-ingredi holist approach
innov due rise local region food servic privat label
custom need help multipl ingredi ii fragment
consum trend well iii gener trend custom cut
would achiev ambit becom
combin dupont nutrit bioscienc unit would creat pf group
sale catapult becom largest player sector
figur pro-forma group would new specialti ingredi
believ achiev manag would particularli proud
note acquir frutarom describ drive signific progress toward
figur size matter buy frutarom enabl signific progress
merg would also enabl compani meet long-held ambit
overtak closest peer givaudan sale
opportun mask issu frutarom
anoth potenti advantag merg giant like would diffus
attent away under-perform frutarom busi frutarom would
account pf sale manag continu believ
busi time return mid-singl digit growth continu view
unlik highlight indigest downgrad under-perform
figur frutarom grown mid-singl digit rate sinc took
alreadi propos new segment structur involv
ad frutarom busi legaci iff tast divis anoth
restat back anoth transform deal could muddi
water
figur redefin busi unit new report
iff-dupont combin would line iff strategi diversifi
adjac suspect anti-trust issu would minor due limit
overlap poor time contempl deal may suggest addit
strateg merit question mark explain next attempt take stab
financi implic analysi come big health warn
insight term potenti transact
deal still specul neither dupont publicli comment
potenti combin nevertheless make attempt financi
 valuat per bloomberg report date dec
revers morri trust rmt transact sharehold hold
pf equiti dupont holder
cost synergi sale excl bioscienc pharma
year
assumpt summaris
million
share price cob dec
new share issu
impli eq valu base market cap
assum base ev equiti valu
take dec bberg articl
financi effect ep accret modest year
main impact iff financi shown assum year
deal like take least year close
model avail upon request
figur ep accret
unit shown
expect nearli accret year
new pro-forma valuat materi scope de-rat
next show pf valuat multipl
assum stock re-rat iff current stand-alone valuat would impli
fair valu upsid
figur fair valu differ pf target multipl
unit shown
yet view signific de-rat like given materi concern
integr handl top challeng frutarom deal ii
manag credibl state near-term focu would bolt-on
 note also iff share price valuat extrem volatil stock
recent trade low ebitda follow disappoint concern
frutarom deal
figur dip ebitda follow disappoint frutarom
assum pf group de-rat ebitda would impli fair valu
summari take cautiou stanc potenti merger
invest case valuat risk
doubt time creat valu frutarom yet multipl
financi execut risk near-term view materi valuat discount vs peer
well deserv ye quarter alway volatil structur maintain
target price base sotp impli
upsid
upsid risk includ faster progress frutarom integr greater
expect synergi retent materi uptick demand rapid declin raw
materi price market share gain favour chang fx especi
downsid
downsid risk includ slower progress frutarom integr lower
expect synergi retent materi slowdown demand rapid increas raw
materi price loss price power increas competition/market share loss
oper issu expens materi chang fx
heidi vesterinen author contributor report herebi certifi view express report accur reflect person view
compani compani secur discuss report part compens directli indirectli relat specif
recommend view express research report
research analyst name involv prepar research report research analyst exan sa includ exan sa branch base
unit kingdom european econom area switzerland associ person exan inc thu regist qualifi
research analyst financi industri regulatori author finra new york stock exchang nyse non-u analyst subject
nasd rule nyse rule restrict commun subject compani public appear trade secur held research analyst
exan sa regul autorit de contrl prudentiel et de regul acpr autorit de march financi amf franc
exan sa branch base european econom area author regul acpr local relev regul
exan sa geneva branch author regul swiss market supervisori author finma
exan sa london branch subject limit regul financi conduct author detail extent regul financi conduct
author avail us upon request exan inc regul finra secur exchang commiss unit state
research analyst respons prepar report receiv compens base upon variou factor includ overal firm revenu may
research analyst respons prepar report member household may relationship compani cover
research report describ number disclosur tabl immedi indic disclosur appli research
analyst respons prepar research report
research analyst respons prepar report member his/her household has/hav financi interest secur subject
company/i indic previou tabl
research analyst respons prepar report member his/her household serv offic director advisori board member
subject company/i indic previou tabl
research analyst respons prepar report receiv compens subject company/i indic previou tabl
exan sa includ exan sa branch base unit kingdom european econom area switzerland exan inc collect exan
may relationship compani cover research report describ number disclosur tabl immedi indic
disclosur appli exan relationship subject company/i
exan benefici own class common equiti secur subject company/i
exan manag co-manag offer equiti secur subject company/i past month
exan receiv compens invest bank servic subject company/i past month invest bank servic
exan regard subject company/i exan distributor underwrit equiti secur offer managed-or co-manag bnp
pariba bnp pariba manag co-manag offer equiti secur subject company/i
exan expect receiv intend seek compens invest bank servic subject company/i next month
exan sa market maker and/or liquid provid secur subject company/i
exan inc receiv compens product servic invest bank servic subject company/i past month
exan inc invest bank servic client relationship subject company/i past month
exan inc non-invest bank securities-rel client relationship subject company/i past month
exan inc non-securities-rel servic relationship subject company/i past month
exan inc market maker secur subject company/i
exan benefici own least long short posit subject company/i
section report research summari target price rate remov present subject company/i prior distribut
sole purpos verifi accuraci factual statement
follow present section report subject compani conclus amend
commit transpar potenti conflict interest bnp pariba
bnp pariba bnpp hold materi ownership interest variou exan entiti exan bnpp enter agreement maintain
independ exan research report bnpp research report publish brand name exan bnp pariba nevertheless sake
transpar separ identifi potenti conflict interest bnpp regard company/ cover research document
bnpp may relationship compani cover research report describ number disclosur tabl immedi
indic disclosur appli bnpp relationship subject company/i
bnpp benefici own class common equiti secur subject company/i
bnpp manag co-manag offer equiti secur subject company/i past month
bnpp act advisor public offer involv subject company/i past month
bnpp receiv compens invest bank servic subject company/i past month
bnpp expect receiv intend seek compens invest bank servic subject company/i next month
member senior bnpp manag member board subject compani
bnpp benefici own least long short posit subject company/i
explan research rate
exan rate rel rate defin perform europ sector european name stock usa sector us
outperform o/p stock expect outperform stock europ sector european name stock usa sector us name
neutral stock expect perform line perform stock europ sector european name stock usa sector
us name invest horizon
under-perform u/p stock expect under-perform stock europ sector european name stock usa sector us name
invest horizon
review rate stock place review signific news possibl chang confirm soon possibl form
restrict rs stock cover exan rate price exan involv equiti capit market transact relat
subject compani
rate nr stock cover exan rate price time
cover nc exan cover compani
distribut exan bnp pariba equiti recommend
exan bnp pariba cover compani compani regulatori reason accord rate exan bnp pariba
exclud statist regulatori reason rate outperform neutral under-perform correspond respect buy hold sell
underli signif howev differ rate rel sector
compani cover exan bnp pariba rate outperform last month exan act underwrit and/or distributor bnp
pariba compani rate bnp pariba act manag co-manag offer equiti secur bnp pariba provid
invest bank servic compani accord rate
compani cover exan bnp pariba rate neutral last month exan act underwrit and/or distributor bnp
pariba compani rate bnp pariba act manag co-manag offer equiti secur bnp pariba provid
invest bank servic compani accord rate
compani cover exan bnp pariba rate under-perform last month exan act underwrit and/or distributor
bnp pariba compani rate bnp pariba act manag co-manag offer equiti secur bnp pariba
provid invest bank servic compani accord rate
exan independ bnp pariba nevertheless order maintain absolut transpar includ categori transact carri bnp
pariba independ exan purpos clariti exclud fix incom transact carri bnp pariba
price rate chart
histor close price target price
date time
report analyst cover stock
result question manag vesterinen
consum ingredi go vesterinen
food hpc consum ingredi ev/ebitda reduc across vesterinen
result question manag vesterinen
consum ingredi live veg vesterinen
indigest downgrad under-perform vesterinen
intern flavor fragranc question investor vesterinen
consum ingredi ceo get paid chang vesterinen
intern flavor fragranc result question vesterinen
intern flavor fragranc tempt yet vesterinen
intern flavor fragranc result question vesterinen
intern flavor fragranc wake smell coffe vesterinen knight
tp
tp
rate tp
tp
tp
initi coverag
latest company-specif disclosur valuat methodolog invest case risk compani cover document
